Edition:
United Kingdom

Gensight Biologics SA (SIGHT.PA)

SIGHT.PA on Paris Stock Exchange

2.95EUR
18 Jan 2019
Change (% chg)

€0.01 (+0.34%)
Prev Close
€2.94
Open
€2.99
Day's High
€3.12
Day's Low
€2.89
Volume
176,572
Avg. Vol
305,708
52-wk High
€7.68
52-wk Low
€1.34

Chart for

About

Gensight Biologics SA is a France-based company, which specializes in the clinical-stage biotechnology and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The Company, through I ts integrated development platform, combines a gene therapy-based approach with... (more)

Overall

Beta: --
Market Cap(Mil.): €122.62
Shares Outstanding(Mil.): 24.00
Dividend: --
Yield (%): --

Financials

  SIGHT.PA Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -- -- --
ROI: -- 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates